← Open Payments lookup

RENE CATHEY: Open Payments

NPI 1770689630 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$338 in 15 payments from 5 companies in 2025. Trend: 2023 $623 · 2024 $589 · 2025 $338

Food & beverage: $338
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$186
Amgen Inc.4$59
Lilly USA, LLC3$49
Sumitomo Pharma America, Inc.2$30
GlaxoSmithKline, LLC.1$14

Products named: BREZTRI, FARXIGA, MOUNJARO, GEMTESA, OTEZLA, REPATHA, EVENITY, SHINGRIX.

Industry payments across MS — which companies pay providers there.